Cargando…
Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody
Autoimmune pulmonary alveolar proteinosis (APAP) is caused by macrophage dysfunction due to anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody. We experienced 2 cases of APAP complicated with sarcoidosis in a 42-year-old woman and a 51-year-old man (age at the sarcoidosis di...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662056/ https://www.ncbi.nlm.nih.gov/pubmed/32611952 http://dx.doi.org/10.2169/internalmedicine.3853-19 |
_version_ | 1783609319805157376 |
---|---|
author | Arai, Toru Kasai, Takahiko Shimizu, Kazunori Kawahara, Kunimitsu Katayama, Kanako Sugimoto, Chikatoshi Hirose, Masaki Okamoto, Hiroyuki Tachibana, Kazunobu Akira, Masanori Inoue, Yoshikazu |
author_facet | Arai, Toru Kasai, Takahiko Shimizu, Kazunori Kawahara, Kunimitsu Katayama, Kanako Sugimoto, Chikatoshi Hirose, Masaki Okamoto, Hiroyuki Tachibana, Kazunobu Akira, Masanori Inoue, Yoshikazu |
author_sort | Arai, Toru |
collection | PubMed |
description | Autoimmune pulmonary alveolar proteinosis (APAP) is caused by macrophage dysfunction due to anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody. We experienced 2 cases of APAP complicated with sarcoidosis in a 42-year-old woman and a 51-year-old man (age at the sarcoidosis diagnosis). APAP preceded sarcoidosis in the woman, and both diseases were diagnosed simultaneously in the man. Sarcoidosis lesions were observed in the lung, skin, and eyes, and the pathological findings of APAP were not marked at the diagnosis of sarcoidosis in either case. Low-grade positive serum anti-GM-CSF autoantibody was suspected to be correlated with the occurrence of sarcoidosis and resolution of APAP. |
format | Online Article Text |
id | pubmed-7662056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-76620562020-11-25 Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody Arai, Toru Kasai, Takahiko Shimizu, Kazunori Kawahara, Kunimitsu Katayama, Kanako Sugimoto, Chikatoshi Hirose, Masaki Okamoto, Hiroyuki Tachibana, Kazunobu Akira, Masanori Inoue, Yoshikazu Intern Med Case Report Autoimmune pulmonary alveolar proteinosis (APAP) is caused by macrophage dysfunction due to anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody. We experienced 2 cases of APAP complicated with sarcoidosis in a 42-year-old woman and a 51-year-old man (age at the sarcoidosis diagnosis). APAP preceded sarcoidosis in the woman, and both diseases were diagnosed simultaneously in the man. Sarcoidosis lesions were observed in the lung, skin, and eyes, and the pathological findings of APAP were not marked at the diagnosis of sarcoidosis in either case. Low-grade positive serum anti-GM-CSF autoantibody was suspected to be correlated with the occurrence of sarcoidosis and resolution of APAP. The Japanese Society of Internal Medicine 2020-06-30 2020-10-15 /pmc/articles/PMC7662056/ /pubmed/32611952 http://dx.doi.org/10.2169/internalmedicine.3853-19 Text en Copyright © 2020 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Arai, Toru Kasai, Takahiko Shimizu, Kazunori Kawahara, Kunimitsu Katayama, Kanako Sugimoto, Chikatoshi Hirose, Masaki Okamoto, Hiroyuki Tachibana, Kazunobu Akira, Masanori Inoue, Yoshikazu Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody |
title | Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody |
title_full | Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody |
title_fullStr | Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody |
title_full_unstemmed | Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody |
title_short | Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody |
title_sort | autoimmune pulmonary alveolar proteinosis complicated with sarcoidosis: the clinical course and serum levels of anti-granulocyte-macrophage colony-stimulating factor autoantibody |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662056/ https://www.ncbi.nlm.nih.gov/pubmed/32611952 http://dx.doi.org/10.2169/internalmedicine.3853-19 |
work_keys_str_mv | AT araitoru autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody AT kasaitakahiko autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody AT shimizukazunori autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody AT kawaharakunimitsu autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody AT katayamakanako autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody AT sugimotochikatoshi autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody AT hirosemasaki autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody AT okamotohiroyuki autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody AT tachibanakazunobu autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody AT akiramasanori autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody AT inoueyoshikazu autoimmunepulmonaryalveolarproteinosiscomplicatedwithsarcoidosistheclinicalcourseandserumlevelsofantigranulocytemacrophagecolonystimulatingfactorautoantibody |